RVd and CyBorD therapies remodel B-cell maturation signaling and alter immune and clonal architecture in multiple myeloma
Zuzana Valuskova, Dana Cholujova, Gabor Beke, Milan Hucko, Maria E. Marinkovicova, Katarina Suroviakova, Lubos Klucar, Lubos Drgona, Merav Leiba, Efstathios Kastritis, David M. Dorfman, Kenneth C. Anderson, Jana Jakubikova · 2025
Read RVd and CyBorD therapies remodel B-cell maturation signaling and alter immune and clonal architecture in multiple myeloma by Zuzana Valuskova, Dana Cholujova, Gabor Beke, Milan Hucko, Maria E. Marinkovicova, Katarina Suroviakova, Lubos Klucar, Lubos Drgona, Merav Leiba, Efstathios Kastritis, David M. Dorfman, Kenneth C. Anderson, Jana Jakubikova (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12919894.txt.
Description
Zuzana Valuskova and a large team study how two drug regimens reshape B-cell maturation in multiple myeloma, in work from 2025. Both regimens pair bortezomib and dexamethasone with either lenalidomide or cyclophosphamide. Bone marrow samples from treated patients, split by response, were profiled with CyTOF and compared with an untreated group.
The regimens left distinct immune patterns across plasma cells, early B cells and naive T cells. Both lowered some regulators and raised Pax-5 across B-cell stages, but each moved other key factors in opposite ways. Stemness markers also shifted. The authors say these shared and split effects can guide precise choice of regimen for each patient.
Catalog record
| CREATOR | Zuzana Valuskova, Dana Cholujova, Gabor Beke, Milan Hucko, Maria E. Marinkovicova, Katarina Suroviakova, Lubos Klucar, Lubos Drgona, Merav Leiba, Efstathios Kastritis, David M. Dorfman, Kenneth C. Anderson, Jana Jakubikova |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |